Patents Assigned to Congqing Fagen Biomedical Inc.
  • Publication number: 20120269795
    Abstract: The present invention provides a humanized recombinant uricase and mutants thereof, wherein the humanized recombinant uricase is a chimeric protein which comprises amino acids of non-human mammal uricase and amino acids of human uricase. The humanized recombinant unease and mutants thereof have reduced immunogenicity in human, and can be used for the treatment of hyperuricemia and gout.
    Type: Application
    Filed: March 12, 2010
    Publication date: October 25, 2012
    Applicant: Congqing Fagen Biomedical Inc.
    Inventors: Kai Fan, Chun Zhang, Xuefeng Ma, Xiang Mei, Chunlan Hu